|
CA2499128C
(en)
|
2002-09-25 |
2012-07-31 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
|
|
FR2845382A1
(fr)
*
|
2002-10-02 |
2004-04-09 |
Sanofi Synthelabo |
Derives d'indazolecarboxamides, leur preparation et leur utilisation en therapeutique
|
|
US20070043079A1
(en)
*
|
2003-04-18 |
2007-02-22 |
Hiromu Habashita |
Heterocyclic compound containing nitrogen atom and use thereof
|
|
EP2256106B1
(en)
|
2003-07-22 |
2015-05-06 |
Astex Therapeutics Limited |
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
|
|
KR20060073930A
(ko)
*
|
2003-08-08 |
2006-06-29 |
버텍스 파마슈티칼스 인코포레이티드 |
통증 치료시 나트륨 또는 칼슘 채널 차단제로서 유용한헤테로아릴아미노설포닐페닐 유도체
|
|
WO2005014554A1
(en)
*
|
2003-08-08 |
2005-02-17 |
Astex Therapeutics Limited |
1h-indazole-3-carboxamide compounds as mapkap kinase modulators
|
|
PL1697378T3
(pl)
|
2003-12-22 |
2008-04-30 |
Memory Pharm Corp |
Indole, 1h-indazole, 1,2-benzoizoksazole i 1,2-benzoizotiazole oraz ich wytwarzanie i zastosowania
|
|
FR2867778B1
(fr)
*
|
2004-03-16 |
2006-06-09 |
Sanofi Synthelabo |
Utilisation de derives d'indazolecarboxamides pour la preparation d'un medicament destine au traitement et a la prevention du paludisme
|
|
WO2005092890A2
(en)
|
2004-03-25 |
2005-10-06 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
|
|
DE602005024677D1
(de)
|
2004-04-22 |
2010-12-23 |
Memory Pharm Corp |
Indole, 1h-indazole, 1,2-benzisoxazole, 1,2-benzoisothiazole, deren herstellung und verwendungen
|
|
RU2386633C2
(ru)
|
2004-05-07 |
2010-04-20 |
Мемори Фармасьютиклз Корпорейшн |
1h-индазолы, бензотиазолы, 1, 2-бензоизоксазолы, 1, 2-бензоизотиазолы и хромоны и их получение и применения
|
|
JP4931823B2
(ja)
|
2004-10-18 |
2012-05-16 |
アムジエン・インコーポレーテツド |
チアジアゾール化合物及び使用方法
|
|
JP2008525464A
(ja)
|
2004-12-22 |
2008-07-17 |
メモリー・ファーマシューティカルズ・コーポレイション |
α−７ニコチン性受容体リガンド並びにその製造及び使用
|
|
US8404718B2
(en)
|
2005-01-21 |
2013-03-26 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors
|
|
AR052559A1
(es)
*
|
2005-01-21 |
2007-03-21 |
Astex Therapeutics Ltd |
Derivados de pirazol para inhibir cdk's y gsk's
|
|
AR054425A1
(es)
|
2005-01-21 |
2007-06-27 |
Astex Therapeutics Ltd |
Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
|
|
CA2621983A1
(en)
*
|
2005-09-09 |
2007-03-22 |
Schering Corporation |
Azafused cyclin dependent kinase inhibitors
|
|
US8008481B2
(en)
*
|
2006-03-31 |
2011-08-30 |
Ericsson Anna M |
Indazole compounds
|
|
US20090142337A1
(en)
*
|
2006-05-08 |
2009-06-04 |
Astex Therapeutics Limited |
Pharmaceutical Combinations of Diazole Derivatives for Cancer Treatment
|
|
US7919504B2
(en)
|
2007-07-17 |
2011-04-05 |
Amgen Inc. |
Thiadiazole modulators of PKB
|
|
US7897619B2
(en)
|
2007-07-17 |
2011-03-01 |
Amgen Inc. |
Heterocyclic modulators of PKB
|
|
WO2009106980A2
(en)
*
|
2008-02-29 |
2009-09-03 |
Pfizer Inc. |
Indazole derivatives
|
|
ES2835553T3
(es)
|
2009-08-10 |
2021-06-22 |
Biosplice Therapeutics Inc |
Inhibidores de indazol de la vía de señalización de Wnt y sus usos terapéuticos
|
|
BR112012002942A2
(pt)
*
|
2009-08-10 |
2015-10-13 |
Epitherix Llc |
indazóis como inibidores da trilha de sinalização de wnt/b-catenina e empregos terapêuticos destes.
|
|
EP2477498A4
(en)
*
|
2009-09-14 |
2013-02-27 |
Merck Sharp & Dohme |
INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE
|
|
SMT201700581T1
(it)
|
2009-12-21 |
2018-01-11 |
Samumed Llc |
1h-pirazolo[3,4-b]piridine e loro usi terapeutici
|
|
JP2013526542A
(ja)
|
2010-05-12 |
2013-06-24 |
アッヴィ・インコーポレイテッド |
キナーゼのインダゾール阻害薬
|
|
WO2012118812A2
(en)
|
2011-02-28 |
2012-09-07 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
|
HUE041576T2
(hu)
|
2011-09-14 |
2019-05-28 |
Samumed Llc |
Indazol-3-karboxamid-származékok és alkalmazásuk Wnt/b-katenin szignalizáló útvonal inhibitorokként
|
|
JP2015506360A
(ja)
*
|
2012-01-06 |
2015-03-02 |
ユニバーシティ・オブ・サウス・フロリダ |
組成物、使用方法および処置方法
|
|
EA024939B1
(ru)
*
|
2012-02-21 |
2016-11-30 |
Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А. |
1h-индазол-3-карбоксамидные соединения в качестве ингибиторов гликогенсинтазы киназы 3-бета
|
|
WO2013124169A1
(en)
|
2012-02-21 |
2013-08-29 |
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. |
Use of 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
|
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
|
SG11201407148XA
(en)
|
2012-05-04 |
2014-11-27 |
Samumed Llc |
1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
|
ME03000B
(me)
*
|
2012-12-21 |
2018-10-20 |
Plexxikon Inc |
Jedinjenja i metode modulacije kinaze i povezane indikacije
|
|
US9908867B2
(en)
|
2013-01-08 |
2018-03-06 |
Samumed, Llc |
3-(benzoimidazol-2-yl)-indazole inhibitors of the Wnt signaling pathway and therapeutic uses thereof
|
|
BR112016021626A2
(pt)
|
2014-03-20 |
2018-05-15 |
Samumed, Llc |
indazol-3-carboxamidas 5-substituídas e preparação e uso das mesmas
|
|
EP3160940A4
(en)
*
|
2014-06-25 |
2018-05-02 |
Epizyme, Inc. |
Substituted benzene and 6,5-fused bicyclic heteroaryl compounds
|
|
WO2016040182A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-1h-imidazo[4,5-c]pyridine and therapeutic uses thereof
|
|
WO2016040180A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040184A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040181A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040193A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
|
WO2016040190A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
|
WO2016040185A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof
|
|
WO2016040188A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
GB201511382D0
(en)
|
2015-06-29 |
2015-08-12 |
Imp Innovations Ltd |
Novel compounds and their use in therapy
|
|
US10285983B2
(en)
|
2015-08-03 |
2019-05-14 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-B] pyridines and therapeutic uses thereof
|
|
WO2017023987A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
|
US10231956B2
(en)
|
2015-08-03 |
2019-03-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
WO2017023993A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-indol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
US10329309B2
(en)
|
2015-08-03 |
2019-06-25 |
Samumed, Llc |
3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
US10195185B2
(en)
|
2015-08-03 |
2019-02-05 |
Samumed, Llc |
3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
WO2017023989A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
US10383861B2
(en)
|
2015-08-03 |
2019-08-20 |
Sammumed, LLC |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
|
US10206908B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
|
WO2017024026A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-indol-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
|
US10206909B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
US10350199B2
(en)
|
2015-08-03 |
2019-07-16 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
|
WO2017023980A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
|
US10604512B2
(en)
|
2015-08-03 |
2020-03-31 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof
|
|
US10463651B2
(en)
|
2015-08-03 |
2019-11-05 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-indazoles and therapeutic uses thereof
|
|
WO2017024025A1
(en)
|
2015-08-03 |
2017-02-09 |
Sunil Kumar Kc |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
US10188634B2
(en)
|
2015-08-03 |
2019-01-29 |
Samumed, Llc |
3-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
WO2017079759A1
(en)
|
2015-11-06 |
2017-05-11 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-c]pyridines and their anti-inflammatory uses thereof
|
|
CN108700594B
(zh)
|
2015-11-18 |
2021-06-29 |
建新公司 |
多囊性肾病的生物标志物及其用途
|
|
AR108325A1
(es)
|
2016-04-27 |
2018-08-08 |
Samumed Llc |
Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
|
|
MY199242A
(en)
|
2016-06-01 |
2023-10-22 |
Samumed Llc |
Process for preparing n-(5-(3-(7-(3-fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide
|
|
BR112019008061A2
(pt)
|
2016-10-21 |
2019-09-17 |
Samumed Llc |
métodos de uso de indazol-3-carboxamidas e seu uso como inibidores da via de sinalização de wnt/b-catenina
|
|
MA46696A
(fr)
|
2016-11-07 |
2019-09-11 |
Samumed Llc |
Formulations injectables à dose unique prêtes à l'emploi
|
|
WO2018094362A1
(en)
|
2016-11-21 |
2018-05-24 |
Translational Drug Development, Llc |
Heterocyclic compounds as kinase inhibitors
|
|
WO2018177781A1
(en)
*
|
2017-03-28 |
2018-10-04 |
Basf Se |
Pesticidal compounds
|
|
JP7369132B2
(ja)
|
2018-02-23 |
2023-10-25 |
サミュメッド リミテッド ライアビリティ カンパニー |
５－ヘテロアリール置換イミダゾール－３－カルボキサミドならびにその調製および使用の方法
|
|
ES2913975T3
(es)
|
2018-05-07 |
2022-06-07 |
Acraf |
Compuestos de 1H-indazol-3-carboxamida como inhibidores de la glucógeno sintasa cinasa-3 beta
|
|
AU2021263383A1
(en)
|
2020-04-29 |
2022-11-24 |
Plexxikon Inc. |
Synthesis of heterocyclic compounds
|
|
CN112778203B
(zh)
*
|
2021-01-29 |
2022-02-15 |
兰州交通大学 |
1h-吲唑-3-羧酸衍生物及格拉斯琼和氯尼达明的制备方法
|
|
CN114605329B
(zh)
*
|
2022-03-28 |
2024-01-26 |
河南中医药大学 |
取代的吲唑甲酰胺或取代的氮杂吲唑甲酰胺类flt3抑制剂及其用途
|
|
CN119997982A
(zh)
|
2022-09-09 |
2025-05-13 |
迈里克斯制药有限公司 |
包含nmt抑制剂的抗体药物偶联物及其用途
|
|
WO2024109642A1
(zh)
*
|
2023-07-28 |
2024-05-30 |
常州大学 |
一种苯并氮杂环类化合物作为β2-肾上腺素受体别构调节剂的应用
|
|
WO2026024674A1
(en)
|
2024-07-22 |
2026-01-29 |
Genesis Therapeutics, Inc. |
Methods of treating skp2-associated cancers
|